Table 1.
Association between JMJD2A expression and disease parameters in 155 cases of breast cancer
|
Total |
JMJD2A |
P
-value |
Correlation coefficient |
|||
---|---|---|---|---|---|---|---|
|
|
0 (−) |
1 (+) |
2 (++) |
3 (+++) |
|
|
n = 11 | n = 56 | n = 53 | n = 35 | ||||
TNM1 stage |
|
|
|
|
|
|
|
I and II |
139 |
10 |
54 |
49 |
26 |
0.004** |
0.227 |
III and IV |
16 |
1 |
2 |
4 |
9 |
||
Tumor size |
|
|
|
|
|
|
|
≤2 cm |
110 |
6 |
48 |
37 |
19 |
0.026* |
0.179 |
2 cm < T ≤5 cm |
42 |
5 |
7 |
14 |
16 |
||
>5 cm |
3 |
0 |
1 |
2 |
0 |
||
Lymph node metastasis |
|
|
|
|
|
|
|
Negative |
100 |
9 |
29 |
35 |
27 |
0.102 |
−0.132 |
Positive |
55 |
2 |
27 |
18 |
8 |
||
Age |
|
|
|
|
|
|
|
<50 years |
46 |
4 |
21 |
13 |
8 |
0.092 | 0.136 |
≥50 years | 109 | 7 | 35 | 40 | 27 |
1TNM stage is a classification of malignant tumors used by the International Federation of Gynecology and Obstetrics (FIGO). T describes the size of primary tumor, N describes nearby lymph nodes that are involved, and M describes distant metastasis. *P <0.05, **P <0.01.